European Journal of Obstetrics & Gynecology and Reproductive Biology
Volume 143, Issue 2 , Pages 69-74 , April 2009

Gynecologic Cancer Intergroup (GCIG) proposals for changes of the current FIGO staging system

  • Edgar Petru

      Affiliations

    • Department of Obstetrics and Gynecology, Medical University of Graz, Auenbruggerplatz 14, A-8036 Graz, Austria
    • On behalf of the GCIG FIGO Working Group.
    • Corresponding Author InformationCorresponding author. Tel.: +43 316 385 81082; fax: +43 316 385 2546.
    • ,
  • Hans-Joachim Lück

      Affiliations

    • Department of Gynecology and Gynecologic Oncology, Horst Schmidt Kliniken, Wiesbaden, Germany
    • On behalf of the GCIG FIGO Working Group.
    • ,
  • Gavin Stuart

      Affiliations

    • Department of Gynecologic Oncology, University of British Columbia, BC, USA
    • On behalf of the GCIG FIGO Working Group.
    • ,
  • David Gaffney

      Affiliations

    • Department of Radiation Oncology, Huntsman Cancer Institute, University of Utah, UT, USA
    • On behalf of the GCIG FIGO Working Group.
    • ,
  • David Millan

      Affiliations

    • Department of Pathology, University of Glasgow, Glasgow, United Kingdom
    • On behalf of the GCIG FIGO Working Group.
    • ,
  • Ignace Vergote

      Affiliations

    • Department of Gynecologic Oncology, Catholic University Hospital Leuven, Leuven, Belgium
    • On behalf of the GCIG FIGO Working Group.

Received 10 May 2008 ,Revised 25 November 2008 ,Accepted 22 December 2008.

References 

  1. Hertel H, Köhler C, Grund D, et al. Radical vaginal trachelectomy combined with laparoscopic pelvic lymphadenectomy: prospective multicenter study of 100 patients with early cervical cancer. Gynecol Oncol. 2006;103:506–511
  2. Plante M, Renaud M, Francois H, Roy M. Vaginal radical trachelectomy: an oncologically safe fertility-preserving surgery. An updated series of 72 cases and review of the literature. Gynecol Oncol. 2004;94:614–623
  3. Girardi F, Burghardt E, Pickel H. Small FIGO stage IB cervical cancer. Gynecol Oncol. 1994;55:427–432
  4. Perez C, Grigsby P, Chao C, et al. Tumor size, irradiation dose, and long-term outcome of carcinoma of the cervix. Int J Radiat Oncol Biol Phys. 1998;41:307–310
  5. Thoms W, Eifel P, Smith T, et al. Bulky endocervical carcinoma: a 23-year experience. Int J Radiat Oncol Biol Phys. 1992;23:491–499
  6. Stehman F, Bundy B, DiSaia P, et al. Carcinoma of the cervix treated with radiation therapy I. Cancer. 1991;67:2776–2785
  7. Logsdon M, Eifel P. FIGO IIIB squamous cell carcinoma of the cervix: an analysis of prognostic factors emphasizing the balance between external beam and intracavitary radiation therapy. Int J Radiat Oncol Biol Phys. 1999;43:763–775
  8. Lanciano R, Martz K, Coia L, Hanks G. Tumor and treatment factors improving outcome in stage III-B cervix cancer. Int J Radiat Oncol Biol Phys. 1991;20:95–100
  9. Mariani A, Webb M, Keeney G, Aletti G, Podratz K. Assessment of prognostic factors in stage IIIA endometrial cancer. Gynecol Oncol. 2002;86:38–44
  10. Kasamatsu T, Onda T, Katsamatu N, et al. Prognostic significance of peritoneal cytology in endometrial carcinoma confined to the uterus. Br J Cancer. 2003;27:245–250
  11. Slomovitz B, Ramondetta L, Lee C, et al. Heterogeneity of stage IIIA endometrial carcinomas: implications for adjuvant therapy. Int. J. Gynecol Cancer. 2005;15:510–516
  12. Tebeu P, Popowski Y, Verkooijen H, et al. Positive peritoneal cytology in early-stage endometrial cancer does not influence prognosis. Br J Cancer. 2004;16:720–724
  13. Scholz H, Lax S, Petru E, Benedicic C, Winter R. Inguinal lymph node metastasis as the presenting symptom of endometrial cancer: a case report. Anticancer Res. 2002;22:2531–2532
  14. Ramahi A, Malviya V, Ataya K, Deppe G. Endometrial carcinoma presenting as a large inguinal mass. Int J Gynecol Obstet. 1989;28:67–70
  15. Creasman W, Odicino F, Maisonneuve , et al. Carcinoma of the corpus uteri. J Epidemiol Biostatist. 2001;6:45–86
  16. Amant F, Moerman Ph, Neven P, Timmerman D, Van Limbergen E, Vergote I. Endometrial Cancer. Lancet. 2005;366:491–505
  17. Kitchener H, Redman C, Swart A, Amos C. ASTEC—a study in the treatment of endometrial cancer: a randomised trial of lymphadenectomy in the treatment of endometrial cancer. Gynecol Oncol. 2006;101:S21–S22
  18. Chan J, Loizzi V, Youssef M, et al. Significance of comprehensive surgical staging in non-invasive papillary serous carcinoma of the endometrium. Gynecol Oncol. 2003;90:181–185
  19. Podratz K, Mariani A, Webb M. Staging and therapeutic value of lymphadenectomy in endometrial cancer. Gynecol Oncol. 1998;70:163–164
  20. Vergote I, De Brabanter J, Fyles A, et al. Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma. Lancet. 2001;357:176–182
  21. Trimbos JB, Vergote I, Bolis G, et al. Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-adjuvant chemotherapy in Ovarian Neoplasm Trial. J Natl Cancer Inst. 2003;95:113–125
  22. Bertelsen K, Holund B, Andersen J, Nielsen K, Stroyer I, Ladehoff P. Prognostic factors and adjuvant treatment in early epithelial ovarian cancer. Int J Gynecol Cancer. 1993;3:211–218
  23. Sjövall K, Nilsson B, Einhorn N. Different types of rupture of the tumor capsule and the impact on survival in early ovarian carcinoma. Int J Gynecol Cancer. 1994;4:333–336
  24. Fader A, Rose P. Role of surgery in ovarian carcinoma. J Clin Oncol. 2007;25:2873–2883
  25. Cliby W, Aletti G, Wilson T, Podratz K. Is it justified to classify patients to stage IIIc epithelial ovarian cancer based on nodal involvement only?. Gynecol Oncol. 2006;103:797–801
  26. Petru E, Lahousen M, Tamussino K, et al. Lymphadenectomy in stage I ovarian cancer. Am J Obstet Gynecol. 1994;170:656–662
  27. Aletti G, Dowdy S, Podratz K, Cliby W. Analysis of factors impacting operability in stage IV ovarian cancer: rationale use of a triage system. Gynecol Oncol. 2007;105:84–89
  28. Benedet J, Turko M, Faiurey R, Boyes D. Squamous carcinoma of the vulva: results of treatment, 1938 to 1976. Am J Obstet Gynecol. 1979;134:201–207
  29. Burger M, Hollema H, Emanuels A, Krans M, Pras E, Bouma J. The importance of the groin node status for the survival of T1 and T2 vulval carcinoma patients. Gynecol Oncol. 1995;57:327–334
  30. Homesley H, Bundy B, Sedlis A, et al. Assessment of current International Federation of Gynecology and Obstetrics staging of vulvar carcinoma relative to prognostic factors for survival. Am J Obstet Gynecol. 1991;164:997–1004
  31. Moskovic E, Shepherd J, Barton D, Trott P, Nasiri N, Thomas M. The role of high resolution ultrasound with guided cytology of groin lymph nodes in the management of squamous cell carcinoma of the vulva: a pilot study. Br J Obstet Gynaecol. 1999;106:863–867
  32. Hoffman M, DeCesare S, Roberts W, Fiorica J, Finan M, Cavanagh D. Upper vaginectomy for in situ and occult superficially invasive carcinoma of the vagina. Am J Obstet Gynecol. 1992;166:30–33
  33. Eddy G, Singh K, Gansler T. Superficially invasive carcinoma of the vagina following treatment for cervical cancer: a report of six cases. Gynecol Oncol. 1990;36:376–379
  34. Nghan NYS. The practicability of FIGO 2000 staging for gestational trophoblastic neoplasia. Int J Gynecol Cancer. 2004;14:202–205

PII: S0301-2115(09)00010-4

doi: 10.1016/j.ejogrb.2008.12.015

European Journal of Obstetrics & Gynecology and Reproductive Biology
Volume 143, Issue 2 , Pages 69-74 , April 2009

Article Tools